After UK, Bahrain approves Pfizer’s coronavirus vaccine for emergency use

Bahrain’s state-owned media reported on Friday that the island kingdom has decided to approve Pfizer-BioNTech’s coronavirus vaccine for emergency use, days after the UK became the first country to do so.


Bahrain on Friday became the second country in the world to grant Emergency Use Authorisation (EUA) for Pfizer’s coronavirus vaccine. Earlier this week, the UK approved Pfizer and its German partner BioNTech’s Covid-19 vaccine for emergency use.

Pfizer has cited clinical trial data to indicate that an efficacy rate of 95 per cent for its mRNA vaccine. Reports have pointed out that Pfizer-BioNTech’s vaccine needs to be stored at minus 70 Celsius.

“The confirmation of approval by the National Health Regulatory Authority of the kingdom of Bahrain followed thorough analysis and review undertaken by the authority of all available data,” news agency AP quoted state-run Bahrain News Agency as saying.

Prior to this, Bahrain had authorised a Chinese experimental Covid-19 vaccine made by Sinopharm for emergency use.

Bahrain, however, is yet to clarify exactly how many doses of the Pfizer-BioNTech coronavirus vaccine it has ordered.

In November of this year, Sheikh Khalifa bin Salman al Khalifa, the prime minister of Bahrain died. The uncle of King Hamad bin Isa al-Khalifa, he was the longest-serving prime minister.

Home to the US Navy’s 5th Fleet, the island nation of Bahrain is located off the coast of Saudi Arabia in the Persian Gulf and is a long-standing ally of the United States and Saudi Arabia.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *